Amiodarone for the treatment and prevention of ventricular fibrillation and ventricular tachycardia
Hugo Van Herendael, Paul DorianDivision of Cardiology, St. Michael’s Hospital, University of Toronto, Toronto, CanadaAbstract: Amiodarone has emerged as the leading antiarrhythmic therapy for termination and prevention of ventricular arrhythmia in different clinical settings because of...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/amiodarone-for-the-treatment-and-prevention-of-ventricular-fibrillatio-a4640 |